Hearing Loss, Bilateral Sensorineural, Progressive
5
0
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
9 treatments under study, led by Line Extension Of The Phonak Audéo B Product Family
Research Leaders
5 sponsors active, led by Sonova AG
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Hearing Screening in Adults Over 50 Years Old
Societal Merit of Intervention on Hearing Loss Evaluation
Quality Control of CE-Certified Phonak Hearing Aids - 2017_27
Quality Control of CE-Certified Phonak Hearing Aids - 2017_13
Quality Control of CE-Certified Phonak Hearing Aids - 2016_37
Research Network
Common Treatments
- Line Extension Of The Phonak Audéo B Product Family2
- Whispered Voice Test1
- Screening Hhia Questionnaire1
- Screening Pure Tone Audiometry1
- Hearing Aid Phonak Virto V1
Active Sponsors
- Sonova AG3
- Radboud University Medical Center1
- Hospital Pardubice1
- The Society of General Practice, J. E. Purkyne Czech Medical Association1
- University Hospital Hradec Kralove1
Top Investigators
Sonova AG
Radboud University Medical Center
University Hospital Hradec Kralove
University Hospital Hradec Kralove
Sonova AG
Related Conditions
- Hearing Loss Sensorineural1
- Presbyacusis1
- Hearing Loss Adultonset1
- Hearing Loss Bilateral1
- Hearing Loss Bilateral Or Unilateral1